首页> Diabetes, obesity & metabolism.> Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease

导出原文传递

翻译打印收藏纠错

第一作者： Rhee, Jinnie J.

作者： Rhee, Jinnie J. ^[1] ; Han, Jialin ; Montez-Rath, Maria E. ; Chertow, Glenn M.

作者单位： 3180 Porter Dr A219, Palo Alto, CA 94304 USA ^[1]

关键词 antidiabetic drug cardiovascular disease GLP-1 pharmacoepidemiology real-world evidence SGLT-2 inhibitor CARDIOVASCULAR OUTCOMES SGLT2 INHIBITORS LOWER RISK METFORMIN DEATH REAL

发布时间 2024-05-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes, obesity & metabolism.

2024年26卷4期

1273-1281页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Diabetes, obesity & metabolism.

2024年26卷4期

1273-1281页

检索历史清除

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease

Diabetes, obesity & metabolism.

相似文献

同项目论文

Diabetes, obesity & metabolism.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease

Diabetes, obesity & metabolism.

相似文献

同项目论文

Diabetes, obesity & metabolism.

相关期刊

检索历史清除